Christian Wilhelm
Marburg An Der Lahn, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic options.
Journal: Cancer genetics
Published: December 09, 2025
Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia.
Journal: Current oncology (Toronto, Ont.)
Published: January 16, 2023
Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor Board.
Journal: Cancers
Published: August 03, 2022
Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping.
Journal: Cytometry. Part B, Clinical cytometry
Published: October 27, 2019
Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial.
Journal: Journal of cancer research and clinical oncology
Published: January 31, 2019
Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation.
Journal: Leukemia & lymphoma
Published: January 16, 2019
Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease.
Journal: Bone marrow transplantation
Published: April 27, 2018
Contrast-Enhanced Ultrasound in Pulmonary Lymphoma: A Small Pilot Study.
Journal: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
Published: May 15, 2017
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial.
Journal: The Lancet. Oncology
Published: May 16, 2014
Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years.
Journal: Gastroenterology
Published: January 20, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026